House Bill 6232
116th Congress(2019-2020)
To require the Secretary of Health and Human Services, through the National Disaster Medical System, to provide for certain laboratory reimbursement for diagnostic testing for COVID-19 in uninsured individuals.
Introduced
Introduced in House on Mar 12, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6232
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
This bill provides appropriations for the Department of Health and Human Services (HHS) to reimburse, through the National Disaster Medical System, the costs of providing COVID-19 (i.e., coronavirus disease 2019) diagnostic testing and services to individuals without health insurance. This system is a coordinated effort by HHS, the Department of Homeland Security, the Department of Defense, and the Department of Veterans Affairs, working in collaboration with states and other appropriate public or private entities, that provides health services, health-related social services, and other appropriate services to respond to the needs of victims of a public health emergency.
March 12, 2020
Sort by most recent
03/12/2020
Referred to the House Committee on Energy and Commerce.
03/12/2020
Introduced in House
Public Record
Record Updated
Feb 8, 2022 11:16:15 PM